Advertisement

Primäre Tumoren der Leber

  • H. Dancygier
Chapter

Zusammenfassung

Die häufigsten Tumoren der Leber sind Metastasen. In den folgenden Kapiteln werden primäre Tumoren der Leber, d. h. solche Neoplasien, die ihren Ursprung in der Leber haben, besprochen. Tabelle 33.1 vermittelt eine Übersicht über primäre Lebertumoren.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Altmann HW (1994) Hepatic neoformations. Path Res Pract 190: 513–577PubMedGoogle Scholar
  2. Anthony PP (1994) Tumours and tumour-like lesions of the liver and biliary tract. In: MacSween RNM, Anthony PP, Scheuer PJ et al. (eds) Pathology of the liver, 3rd ed. Churchill Livingstone, Edinburgh, pp 635–711Google Scholar
  3. International Working Party of World Congress of Gastroenterology (1995) Terminology of nodular lesions of the liver. Hepatology 22: 983–993Google Scholar
  4. Ishak KG, Anthony PP, Sobin LH (1994) WHO histological typing of tumours of the liver, 2nd ed. Springer, Berlin Heidelberg New YorkGoogle Scholar
  5. Ishak KG, Goodman ZD, Stocker JT (2001) Tumors of the liver and intrahepatic bile ducts. Armed Forces Institute of Pathology, Washington DCGoogle Scholar
  6. Wittekind C, Tannapfel A (2000) Tumoren der Leber. In: Denk H, Dienes HP, Diillmann J et al. (Hrsg) Pathologie der Leber und Gallenwege. Springer, Berlin Heidelberg New York, S 87l–939Google Scholar
  7. Cohen C, Lawson D, DeRose PB (1998) Sex and androgenic steroid receptor expression in hepatic adenomas. Hum Pathol 29: 1428–1432PubMedGoogle Scholar
  8. Cosme A, Horrajada JP, Vidaur F et al. (1995) Systemic amyloidosis induced by oral contraceptive-associated hepatocellular adenoma: a l3 year follow up. Liver 15: 164–167PubMedGoogle Scholar
  9. Edmondson HA, Henderson B, Benton B (1976) Liver cell adenomas associated with the use of oral contraceptives. N Engl J Med 294: 470–472PubMedGoogle Scholar
  10. Foster JH, Berman MM (1994) The malignant transformation of liver cell adenomas. Arch Surg 129: 712–7l7PubMedGoogle Scholar
  11. Khoo US, Nicholls JM, Lee JS et al. (1994) Cholestatic liver cell adenoma in a child with hirsutism and elevated serum levels of cortisol and ACTH. Histopathology 25: 586–588PubMedGoogle Scholar
  12. Rooks JB, Ory HW, Ishak KG et al. (1979) Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242: 644–648PubMedGoogle Scholar
  13. Smit GP, Fernandes J, Leonard JV et al. (1990) The long-term outcome of patients with glycogen storage diseases. J Inherit Metab Dis 13: 411–418PubMedGoogle Scholar
  14. Thyssell H, Ingvar C, Gustafson T et al. (1986) Systemic reactive amyloidosis caused by hepatocellular adenoma. A case report. J Hepatol 2: 450–457Google Scholar
  15. Classen M, Elster K, Pesch HJ et al. (1970) Portal hypertension caused by partial nodular transformation of the liver. Gut 11: 245–249PubMedGoogle Scholar
  16. Colina F, Alberti N, Solis JA et al. (1989) Diffuse nodular regenerative hyperplasia of the liver (DNRH). A clinicopathological study of 24 cases. Liver 9: 253–265PubMedGoogle Scholar
  17. Nakhleh RE, Snover DC (1988) Use of alpha-1-antitrypsin in the diagnosis of nodular regenerative hyperplasia of the liver. Hum Pathol 19: 1048–1052PubMedGoogle Scholar
  18. Soliz-Herruzo JA, Colina-Ruizdelgado FA (1983) Nodular regenerative hyperplasia of the liver. Hepatogastroenterology 30: 171–173Google Scholar
  19. Stromeyer FW, Ishak KG (1981) Nodular transformation (nodular regenerative hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol 12: 60–71PubMedGoogle Scholar
  20. Wanless IR (1990) Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 11: 787–797PubMedGoogle Scholar
  21. Butron Vila MM, Haot J, Desmet VJ (1984) Cholestatic features in focal nodular hyperplasia of the liver. Liver 4: 387–395Google Scholar
  22. Cherqui D, Rahmouni A, Charlotte F et al. (1995) Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 22: 1674–1681PubMedGoogle Scholar
  23. Fukukura Y, Nakashima O, Kusaba A et al. (1998) Angioarchitecture and blood circulation in focal nodular hyperplasia of the liver. J Hepatol 29: 470–475PubMedGoogle Scholar
  24. Gaffey MJ, Iezzoni JC, Weiss LM (1996) Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol 148: 1089–1096PubMedGoogle Scholar
  25. Goldin RD, Rose DS (1990) Focal nodular hyperplasia of the liver associated with intracranial vascular malformation. Gut 31:554–555Google Scholar
  26. Mathieu D, Zafrani ES, Anglade MC et al. (1989) Association of focal nodular hyperplasia and hepatic hemangioma. Gastroenterology 97: 154–157PubMedGoogle Scholar
  27. Pain JA, Gimson AE, Williams R et al. (1991) Focal nodular hyperplasia of the liver: results of treatment and options on management. Gut 32: 524–527PubMedGoogle Scholar
  28. Paradis V, Laurent A, Flejou JF et al. (1997) Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation. Hepatology 26: 891–895PubMedGoogle Scholar
  29. Wanless IR, Albrecht S, Bilbao J et al. (1989) Multiple focal hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome. Mod Pathol 2: 456–462PubMedGoogle Scholar
  30. Whelan TJ, Baugh JH, Chandor S (1973) Focal nodular hyperplasia of the liver. Ann Surg 177: 150–158PubMedGoogle Scholar
  31. Devaney K, Goodman ZD, Ishak KG (1994) Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol l8: 1078–1091Google Scholar
  32. Ishak KG, Willis GW, Cummis SD et al. (1977) Biliary cystadenoma and cystadenocarcinoma: report of 14 cases and review of the literature. Cancer 29: 322–338Google Scholar
  33. Siebenkotten V, Wennig M, Malms J et al. (1999) Ein zystischer echinokokkenähnlicher Lebertumor. Z Gastroenterol 37: 379–383PubMedGoogle Scholar
  34. Woods GL (1981) Biliary cystadenocarcinoma. Case report of hepatic malignancy originating in benign cystadenoma. Cancer 47: 2936–2940PubMedGoogle Scholar
  35. Beavers KL, Fried MW, Johnson MW et al. (2001) Orthotopic liver transplantation for biliary papillomatosis. Liver Transpl 7:264–265Google Scholar
  36. Gunven P, Gorsetman J, Ohlsen H et al. (2000) Six-year recurrence free survival after intraluminal iridium-192 therapy for human bilobar biliary papillomatosis. Cancer 89: 69–73PubMedGoogle Scholar
  37. Kim YS, Myung SI, Kim SY et al. (1998) Biliary papillomatosis: clinical, cholangiographic and cholangioscopic findings. Endoscopy 30: 763–767PubMedGoogle Scholar
  38. Mercadier M, Bodard M, Fingerhut A et al. (1984) Papillomatosis of the intrahepatic bile ducts. World J Surg 8: 30–35PubMedGoogle Scholar
  39. Wang YJ, Lee SD, Lai KH et al. (1993) Primary biliary cystic tumors of the liver. Am J Gastroenterol 88: 599–603PubMedGoogle Scholar
  40. Adams YG, Hunos AG, Fortnes JG (1970) Giant haemangiomas of the liver. Ann Surg 172: 239–245Google Scholar
  41. Dehner LP, Ishak KG (197l) Vascular tumors of the liver in infants and children. Arch Pathol 92: 101–111Google Scholar
  42. Gandolfi L, Leo P, Solmi L et al. (1991) Natural history of hepatic haemangiomas: clinical and ultrasound study. Gut 32: 677–680PubMedGoogle Scholar
  43. Gibney RG, Hendin AP, Cooperberg PL (1987) SonographicalIy detected hepatic haemangiomas: absence of change over time. Am J Roentgenol 149: 953–957Google Scholar
  44. Hobbs KEF (1990) Hepatic haemangiomas. World J Surg 14: 468–47lPubMedGoogle Scholar
  45. Riesener KP, Treutner KH, Treumann T et al. (1990) Das Leberhämangiom. Teil 1. Diagnostik, Spontanverlauf, Komplikationen. Leber Magen Darm 20: 218–223PubMedGoogle Scholar
  46. Sugimura H, Tange T, Yamaguchi K et al. (1986) Systemic haemangiomatosis. Acta Pathol Jpn 36: 1089–1098PubMedGoogle Scholar
  47. Wanless IR, Gryfe A (1986) Nodular transformation of the liver in hereditary hemorrhagic telangiectasia. Arch Pathol Lab Med 110: 331–335PubMedGoogle Scholar
  48. Dehner LP, Ishak KG (197l) Vascular tumors of the liver in infants and children: a study of 30 cases and review of the literature. Arch Pathol 92: 101–111Google Scholar
  49. Laird WP, Friedman S, Koop CE et al. (1976) Hepatic haemangiomatosis. Successful management by hepatic artery ligation. Am J Dis Child 130: 657–659PubMedGoogle Scholar
  50. Selby DM, Stocker JT, Ishak KG (1992) Angiosarcoma of the liver in childhood. A clinicopathologic and follow-up study of 10 cases. Pediatr Pathol 12: 485–489PubMedGoogle Scholar
  51. Stanley P, Geer GD, Miller JH et al. (1989) Infantile hepatic haemangiomas. Cancer 64: 936–949PubMedGoogle Scholar
  52. Van Steenbergen W, Joosten E, Marchal G et al. (1985) Hepatic lymphangiomatosis. Report of a case and review of the literature. Gastroenterology 88: 1968–1972PubMedGoogle Scholar
  53. Ahmadi T, Itai Y, Takahashi M et al. (1998) Angiomyolipoma of the liver: significance of CT and MR dynamic study. Abdom Imaging 23: 520–526PubMedGoogle Scholar
  54. Block S, Theilmann L (2000) Angiomyolipom der Leber. Dtsch Med Wochenschr 125: 743–745PubMedGoogle Scholar
  55. Dalle I, Sciot R, de Vos R et al. (2000) Malignant angiomyoliporna of the liver: a hitherto unreported variant. Histopathology 36: 443–450PubMedGoogle Scholar
  56. Fetsch PA, Fetsch JF, Marincola FM et al. (1998) Comparison of melanoma antigen recognized by T cells (MART-1) to HMB-45: additional evidence to support a common lineage for angiomyolipoma, lymphangiomyomatosis, and clear cell sugar tumor. Mod Pathol 11: 699–703PubMedGoogle Scholar
  57. Fukukura Y, Fujuyoshi F, Inoue H et al. (2000) Focal fatty infiltration in the posterior aspect of hepatic segment IV: relationship to pancreaticoduodenal venous drainage. Am J Gastroenterol 95: 3590–3595PubMedGoogle Scholar
  58. Goodman ZD, Ishak KG (1994) Angiomyolipomas of the liver. Am J Surg Pathol 8: 745–750Google Scholar
  59. Guidi G, Catalano O, Rotondo A (1997) Spontaneous rupture of a hepatic angiomyolipoma: CT findings and literature review. Eur Radiol 7: 335–337PubMedGoogle Scholar
  60. Karhunen PJ (1985) Hepatic pseudolipoma. J Clin Pathol 38: 877–879PubMedGoogle Scholar
  61. Langner C, Homayounfar K, Ruten B et al. (2001) Gleichzeitiges Auftreten von Angiomyolipom, fokaler nodulärer Hyperplasie, cholangiozellulärem Adenom und Hämangiom in der Leber. Pathologe 22: 417–423PubMedGoogle Scholar
  62. Nonomura A, Mizukami Y, Kadoya M (1994) Angiomyolipoma of the liver. A collective review. J Gastroenterol 29: 95–105PubMedGoogle Scholar
  63. Moran CA, Ishak KG, Goodman ZD (1998) Solitary fibrous tumor of the liver: a clinicopathologic and immunohistochemical study of nine cases. Ann Diagn Pathol 2: 1–7PubMedGoogle Scholar
  64. Pack GT, Baker HW (1953) Total right hepatic lobectomy. Report of a case. Ann Surg 138: 253–258PubMedGoogle Scholar
  65. Pecorella I, Ciardi A, Memeo L et al. (1999) Inflammatory pseudotumor of the liver — evidence for malignant transformation. Pathol Res Pract 195: 115–120PubMedGoogle Scholar
  66. Schmid A, Janig D, Bohuszlavizki A et al. (1996) Inflammatory pseudotumor of the liver presenting as incidentaloma: report of a case and review of the literature. Hepatogastroenterology 43: 1009–10 14PubMedGoogle Scholar
  67. Shek TWH, Ng IOL, Chan KW (1993) Inflammatory pseudotumor of the liver. Report of four cases and review of the literature. Am J Surg Pathol l7: 231–238Google Scholar
  68. Aihara T, Noguchi S, Sasaki Y et al. (1996) Clonal analysis of precancerous lesions of hepatocellular carcinoma. Gastroenterology 111: 455–461PubMedGoogle Scholar
  69. Allgaier HP, Deibert P, Zuber I et al. (1998) Perkutane Behandlung von Lebertumoren durch interstitielle Radio-Frequenz-Thermoablation. Eine neue therapeutische Strategie. Dtsch Med Wochenschr 123: 907–911PubMedGoogle Scholar
  70. American Joint Committee on Cancer Staging Manual (1997) 5th ed. Lippicott-Raven, PhiladelphiaGoogle Scholar
  71. Anthony PP, Vogel CL, Barker LF (1973) Liver cell dysplasia: a premalignant condition. J Clin Pathol 26: 217–223PubMedGoogle Scholar
  72. Anthony PP, James K (1987) Pedunculated hepatocellular carcinoma. Is it an entity? Histopathology 11: 402–414Google Scholar
  73. Beasley RP (1988) Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61: 1942–1956PubMedGoogle Scholar
  74. Bismuth H, Majno PE, Adam R (1999) Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 19: 311–322PubMedGoogle Scholar
  75. Bolondi L, Sofia S, Siringo S et al. (2001) Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 48:251–259Google Scholar
  76. Borzio M, Bruno S, Roncalli M et al. (1995) Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology 108: 812–817PubMedGoogle Scholar
  77. Bruix J, Sherman M, Llovet JM et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 35: 421–430PubMedGoogle Scholar
  78. Chen CJ, Liang KY, Chang AS et al. (1991) Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 13: 398–406PubMedGoogle Scholar
  79. Collier J, Sherman M (1998) Screening for hepatocellular carcinoma. Hepatology 27: 273–278PubMedGoogle Scholar
  80. Colombo M, de Franchis R, Del Ninno E et al. (1991) Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 325: 675–680PubMedGoogle Scholar
  81. Conti JA, Kemeny N (1992) Type Ia glycogenosis asssociated with hepatocellular carcinoma. Cancer 69: 1320–1322PubMedGoogle Scholar
  82. D’Errico A, Baccarini P, Fiorentino M et al. (1996) Histogenesis of primary liver carcinomas: strengths and weaknesses of cytokeratin profile and mRNA detection. Hum Pathol 27: 599–604PubMedGoogle Scholar
  83. Deugnier YM, Guyader D, Crantock L et al. (1993) Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases. Gastroenterology 104: 228–234PubMedGoogle Scholar
  84. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver. A study of 100 cases among 48900 necropsies. Cancer 7:462–503Google Scholar
  85. El-Serag HB (2001) Epidemiology of hepatocellular carcinoma. Clin Liver Dis 5: 87–107PubMedGoogle Scholar
  86. El-Serag HB, Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340: 745–750PubMedGoogle Scholar
  87. El-Serag HB, Mason AC, Key C (2001) Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 33: 62–65PubMedGoogle Scholar
  88. El-Serag HB, Richardson PA, Everhart JE (2001) The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans. Am J Gastroeneterol 96: 2462–2467Google Scholar
  89. Emile JF, Adam R, Sebagh M et al. (2000) Hepatocellular carcinoma with lymphoid stroma: a tumour with good prognosis after liver transplantation. Histopathology 37: 523–529PubMedGoogle Scholar
  90. Eriksson S, Carlson J, Velez R (1986) Risk of cirrhosis and primary liver cancer in alpha-1-antitrypsin deficiency. N Engl J Med 314: 736–739PubMedGoogle Scholar
  91. Fargion S, Fracanzani AL, Piperno A et al. (1994) Prognostic facors for hepatocellular carcinoma in genetic hemochromatosis. Hepatology 20: 1426–1431PubMedGoogle Scholar
  92. Francanzani AL, Taioli E, Sampietro M et al. (2001) Liver cancer risk is increased in patients with pophyria cutanea tarda in comparison to matched control patients with chronic liver disease. J Hepatol 35: 498–503Google Scholar
  93. Gambarin-Gelwan M, Wolf DC, Shapiro R et al. (2000) Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol 95: 1535–1538PubMedGoogle Scholar
  94. Ganne-Carrie N, Chastang C, Chapel F et al. (1996) Predictive score for the development of hepatocellular carcinoma and additional value of liver cell dysplasia in Western patients with cirrhosis. Hepatology 23: 1112–1118PubMedGoogle Scholar
  95. Hanazaki K, Kajikawa S, Koide N et al. (2001) Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitic C viral infection: univariate and multivariate analysis. Am J Gastroenterol 96: 1243–1250PubMedGoogle Scholar
  96. International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22: 983–993Google Scholar
  97. Jonas S, Bechstein WO, Steinmüller T et al. (2001) Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 33: 1080–1086PubMedGoogle Scholar
  98. Kanai T, Hirohashi S, Upton M et al. (1987) Pathology of small hepatocellular carcinoma. Cancer 60: 810–819PubMedGoogle Scholar
  99. Kauppinen R, Mustajoki P (1988) Acute hepatic porphyria and hepatocellular carcinoma. Br J Cancer 57: 117–120PubMedGoogle Scholar
  100. Kekule AS, Lauer U, Weiss L et al. (1993) Hepatitis B virus transactivator HBX uses a tumour promoter signalling pathway. Nature 361: 742–745PubMedGoogle Scholar
  101. Kew MC (2000) Hepatocellular carcinoma. A century of progress. Clin Liver Dis 4: 257–268PubMedGoogle Scholar
  102. Khan MA, Combs CS, Brunt EM et al. (2000) Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 32: 792–797PubMedGoogle Scholar
  103. Kojiro M, Nakashima O (1999) Histopathologic evolution of hepatocellular carcinoma with special reference to small early stage tumors. Semin Liver Dis 19: 287–296PubMedGoogle Scholar
  104. Kouroumalis E, Skordilis P, Thermos K et al. (1998) Treatment of hepatocellular carcinoma with octreotide: a randomized controlled study. Gut 42: 442–447PubMedGoogle Scholar
  105. Leong ASY, Sarmunen RT, Tsui MWS et al. (1998) Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Histopathology 33: 318–324PubMedGoogle Scholar
  106. Leung TWT, Patt YZ, Lau WY et al. (1999) Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clin Cancer Res 5: 1676–1681PubMedGoogle Scholar
  107. Liebman HA, Furie BC, Tong MJ et al. (1984) Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 310: 1427–1431PubMedGoogle Scholar
  108. Llovent JM, Vilana R, Bru C et al. (2001) Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 33: 1124–1129Google Scholar
  109. Mazzaferro V, Regalia E, Doci R et al. (1996) Liver transplantation for treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 643–649Google Scholar
  110. Natarajan S, Theise ND, Thung SN et al. (1997) Large-cell change of hepatocytes in cirrhosis may represent a reaction to prolonged cholestasis. Am J Surg Pathol 21: 312–318PubMedGoogle Scholar
  111. Niederau C, Fischer R, Sonnenberg A et al. (1985) Survival and causes of death in cirrhotic and non-cirrhotic patients with primary haemochromatosis. N Engl J Med 313: 1256–1262PubMedGoogle Scholar
  112. Nomura F, Ishijima M, Kuwa K et al. (1999) Serum des-gammacarboxy prothrombin levels determined by a new generation of sensitive immunoassays in patients with small-sized hepatocellular carcinoma. Am J Gastroenterol 94: 650–654PubMedGoogle Scholar
  113. Okuda K, Ohtsuki T, Obata H et al. (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 56: 918–928PubMedGoogle Scholar
  114. Schafer DF, Sorrell MF (1999) Hepatocellular carcinoma. Lancet 353: 1253–1257PubMedGoogle Scholar
  115. Scheuer PJ, Lefkowicz JH (2000) Liver biopsy interpretation, 6th ed. Saunders, PhiladelphiaGoogle Scholar
  116. Sell S (2001) Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology 33: 738–750PubMedGoogle Scholar
  117. Sherman M, Peltekian KM, Lee C (1995) Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 22: 432–438PubMedGoogle Scholar
  118. Shiomi S, Nishiguchi S, Ishizu H et al. (2001) Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma. Am J Gastroenterol 96: 1877–1880PubMedGoogle Scholar
  119. Simson IM (1982) Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in South Africa. Gastroenterology 82: 171–178PubMedGoogle Scholar
  120. Stickel F, Schuppan D, Hahn EG et al. (2002) Cocarcinogenic effects of alcohol in hepatocarcinogenesis. Gut 51: 132–139PubMedGoogle Scholar
  121. Szmuness W (1978) Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol 24:40–69Google Scholar
  122. Takayama T, Makuuchi M, Hirohashi S et al. (1998) Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 28: 1241–1246PubMedGoogle Scholar
  123. Takeda Y, Togashi H, Shinzawa H et al. (2000) Case report: spontaneous regression of hepatocellular carcinoma and review of the literature. J Gastroenterol Hepatol 15: 1079–1086PubMedGoogle Scholar
  124. Tannapfel A, Wittekind C (2001) Praneoplasien der Leber. Definition, Differenzialdiagnose, klinische Konsequenz. Pathologe 22: 399–406PubMedGoogle Scholar
  125. The Cancer of the Liver Italian Program (CLIP) Investigators (2000) Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 31: 840–845Google Scholar
  126. Tradati F, Colombo M, Mannucci PM et al. (1998) A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C. The study group of the association of Italian hemophiliac centers. Blood 91: 1173–1177PubMedGoogle Scholar
  127. Ueno S, Tanabe G, Sako K et al. (2001) Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Hepatology 34: 529–534PubMedGoogle Scholar
  128. Venook AP, Warren RS (2001) Hepatocellular carcinoma. Semin Oncol 28: 439–534Google Scholar
  129. Wada Y, Nakashima O, Kutami R et al. (1998) Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology 27: 407–414PubMedGoogle Scholar
  130. Watanabe S, Okita K, Harada T et al. (1983) Morphologic studies of the liver cell dysplasia. Cancer 51: 2197–2205PubMedGoogle Scholar
  131. Weinberg AG, Mize CE, Worthan HG (1976) The occurrence of hepatoma in the chronic form of hereditary tyrosinemia. J Pediatr 88: 434–438PubMedGoogle Scholar
  132. Yuen MF, Cheng CC, Lauder IJ et al. (2000) Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience (in process citation). Hepatology 31: 330–335PubMedGoogle Scholar
  133. Berman MA, Burnham JA, Sheahan DG (1988) Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature. Hum Pathol 19: 784–794PubMedGoogle Scholar
  134. Craig JR, Peters RL, Edmondson HA et al. (1980) Fibrolamellar carcinoma of the liver. A tumor of adolescents and young adults with distinctive cIinico-pathological features. Cancer 46:372–379Google Scholar
  135. Houben KE, McCall JL (1999) Liver transplantation for hepatocellular carcinoma in patients without underlying liver disease: a systematic review. Liver Transpl Surg 5: 91–95PubMedGoogle Scholar
  136. Pinna AD, Iwatsuki S, Lee RG et al. (1997) Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 26: 877–883PubMedGoogle Scholar
  137. Ringe B, Wittekind C, Weimann A et al. (1992) Results of hepatic resection and transplantation for fibrolamellar carcinoma. Surg Gynecol Obstet 175: 299–305PubMedGoogle Scholar
  138. Ruffin MT (1990) Fibrolamellar hepatoma. Am J Gastroenterol 85:577–581Google Scholar
  139. Sirivatanauksorn Y, Sirivatanauksorn V, Lemoine NR et al. (2001) Genomic homogeneity in fibrolamellar carcinomas. Gut 49: 82–86PubMedGoogle Scholar
  140. Sorelde O, Czerniak A, Bradpiece H et al. (1986) Characteristics of fibrolamellar hepatocellular carcinoma: a study of nine cases and a review of the literature. Am J Surg 151: 518–523Google Scholar
  141. Conran RM, Hitchcock CL, Waclawiw MA et al. (1992) Hepatoblastoma: the prognostic significance of histologic type. Pediatr Pathol 12: 167–183PubMedGoogle Scholar
  142. Ishak KG, Glunz PR (1967) Hepatoblastoma and hepatocarcinoma in infancy and childhood. Cancer 20: 396–422PubMedGoogle Scholar
  143. Koneru B, Flye MW, Busuttil RW et al. (1991) Liver transplantation for hepatoblastoma. The American experience. Ann Surg 213: 118–121PubMedGoogle Scholar
  144. Stocker JT (1990) Hepatic tumours. In: Balistreri WF, Stocker JT (eds) Paediatric hepatology. Hemisphere, New York, pp 399–488Google Scholar
  145. Van Eyken P, Sciot R, Callea F et al. (1990) A cytokeratin-immunohistochemical study of hepatoblastoma. Hum Pathol 21:302–308Google Scholar
  146. Weinberg AG, Finegold MJ (1983) Primary hepatic tumors of childhood. Hum Pathol 14: 512–537PubMedGoogle Scholar
  147. Wittekind C, Tannapfel A (2000) Tumoren der Leber. In: Denk H, Dienes HP, Düllimann J et al. (Hrsg) Pathologie der Leber und Gallenwege. Springer, Berlin Heidelberg New York, S 871–939Google Scholar
  148. Altaee MY, Johnson PJ, Farrant JM et al. (1991) Etiological and clinical characteristics of peripheral and hilar cholangiocarcinoma. Cancer 68: 2051–2055PubMedGoogle Scholar
  149. Bismuth H, Nakache R, Diamond T (1992) Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 215:31–38Google Scholar
  150. Foutch PG, Kerr DM, Harlan JR et al. (1990) Endoscopic retrograde wire-guided brush cytology for diagnosis in patients with malignant obstruction of the bile duct. Am J Gastroenterol 85: 791–795PubMedGoogle Scholar
  151. Klatskin G (1965) Adenocarcinoma of the hepatic duct and its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 38: 241–256PubMedGoogle Scholar
  152. Muro A, Müller PR, Ferrucci JT et al. (1983) Bile cytology: a routine addition to percutaneous biliary drianage. Radiology 149: 846–847PubMedGoogle Scholar
  153. Nagorney DM, Donohue JH, Farrell MB et al. (1993) Outcomes after curative resections of cholangiocarcinoma. Arch Surg 128: 871–877PubMedGoogle Scholar
  154. Nakeeb A, Pitt HA, Sohn TA et al. (1996) Cholangiocarcinoma. A spectrum of intrahepatic, perihilar and distal tumors. Ann Surg 224: 463–475PubMedGoogle Scholar
  155. Nordback IH, Pitt HA, Coleman JA et al. (1994) Unresectable hilar cholangiocarcinoma: percutaneous versus operative palliation. Surgery 115: 597–603PubMedGoogle Scholar
  156. Pichlmayr R, Lamesch P, Weimann A et al. (1995) Surgical treatment of cholangiocellular carcinoma. World J Surg 19: 83–88PubMedGoogle Scholar
  157. Pitt HA, Dooley WC, Yeo Cj et al. (1995) Malignancies of the biliary tree. Curr Prob Surg 32: 1–100Google Scholar
  158. Rosen CB, Nagorney DM, Wiesner RH et al. (1991) Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 213: 21–25PubMedGoogle Scholar
  159. Alrenga DP (1975) Primary angiosarcoma of the liver. Int Surg 60: 198–203PubMedGoogle Scholar
  160. Andries GH, Kaump H (1944) Multiple malignant hemangiomas of the liver. Am J Clin Pathol 46: 803–810Google Scholar
  161. Awan S, Davenport M, Portmann B et al. (1996) Angiosarcoma of the liver in children. Pediatr Surg 31: 1729–1732Google Scholar
  162. Buetow PC, Buck JL, Ros PR et al. (1994) Malignant vascular tumors of the liver. Radiologic-pathologic correlation. From the archives of the AFIP. Radiographies 14: 153–166Google Scholar
  163. Creech JL Jr, Johnson MN (1974) Angiosarcoma of the liver in the manufacture of polyvinyl chloride. J Occup Med 16: 150–151PubMedGoogle Scholar
  164. Guarda LA, Ordonez NG, Smith LG Jr et al. (1982) Immunoperoxidase localization of factor VIII in angiosarcomas. Arch Pathol Lab Med 106: 515–516PubMedGoogle Scholar
  165. Ishak KG (1976) Malignant mesenchymal tumors of the liver. In: Okuda K, Peters RL (eds) Hepatocellular carcinoma. Wiley, New York, pp 247–307Google Scholar
  166. Ito Y, Kojiro M, Nakashima T et al. (1988) Pathomorphologic characteristics of 102 cases of thorotrast-related hepatocellular carcinoma, cholangiocarcinoma, and hepatic angiosarcoma. Cancer 62: 1153–1162PubMedGoogle Scholar
  167. Kasper ML, Schonfield L, Strom RL et al. (1984) Hepatic angiosarcoma and bronchioloalveolar carcinoma induced by Fowler’s solution. JAMA 252: 3407–3408PubMedGoogle Scholar
  168. Levy DW, Rindsberg S, Friedman AC et al. (1986) Thorotrast induced hepatosplenic neoplasia: CT identification. Am J Roentgenol 146: 997–1004Google Scholar
  169. Locker GY, Doroshow JH, Zwelling LA et al. (1979) The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature. Medicine (Baltimore) 58: 48–64Google Scholar
  170. MacMohan HE, Murphy AS, Bates MI (1947) Endothelial cell sarcoma ofliver following thorotrast injections. Am J Pathol 23: 585–611Google Scholar
  171. Mani H, van Thiel DH (2001) Mesenchymal tumors of the liver. Clin Liver Dis 5: 219–257PubMedGoogle Scholar
  172. Penn I (1991) Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 110: 726–735PubMedGoogle Scholar
  173. Regelson W, Kim U, Ospina J et al. (1968) Hemangioendothelial sarcoma of liver from chronic arsenic intoxication by Fowler’s solution. Cancer 21: 514–522PubMedGoogle Scholar
  174. Soini Y, Welsh JA, Ishak KG et al. (1995) p53 mutations in primary hepatic angiosarcomas not associated with vinyl chloride exposure. Carcinogenesis 16: 2879–2881PubMedGoogle Scholar
  175. Demetris AJ, Minervini M, Raikow RB et al. (1997) Hepatic epithelioid hemangioendothelioma. Am J Surg Pathol 21: 263–270PubMedGoogle Scholar
  176. Ishak KG, Sesterhenn IA, Goodman ZD et al. (1984) Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases. Hum Pathol 15: 839–852PubMedGoogle Scholar
  177. Läuffer JM, Zimmermann A, Krähenbühl L et al. (1996) Epithelioid hemagioendothelioma of the liver. A rare hepatic tumor. Cancer 78: 2318–2327PubMedGoogle Scholar
  178. Makhlouf HR, Ishak KG, Goodman ZD (1999) Epithelioid hemangioendothelioma of the liver. A clinicopathologic study of 137 cases. Cancer 85: 562–582PubMedGoogle Scholar
  179. Taege C, Holzhausen HJ, Günter G et al. (1999) Das maligne epitheloide Hämangioendotheliom der Leber. Ein sehr seltener Tumor im Kindesalter. Pathologe 20: 345–350PubMedGoogle Scholar
  180. Walsh MW, Hytiroglou P, Thung SN et al. (1998) Epithelioid hemangioendothelioma of the liver mimicking Budd-Chiari syndrome. Arch Pathol Lab Med 122: 846–848PubMedGoogle Scholar
  181. Weiss SW, Enzinger FM (1982) Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer 50: 970–981PubMedGoogle Scholar
  182. Lauwers GY, Grant LD, Donnelly WH et al. (1997) Hepatic undifferentiated (embryonal) sarcoma arising in a mesenchymal hamartoma. Am J Surg Pathol 21: 1248–1254PubMedGoogle Scholar
  183. Leuschner I, Schmidt D, Harms D (1990) Undifferentiated sarcoma of the liver in childhood: morphology, flow cytometry and literature review. Hum Pathol 21: 68–76PubMedGoogle Scholar
  184. Perilongo G, Carli M, Sainati L et al. (1987) Undifferentiated (embryonal) sarcoma of the liver in childhood: results of a retrospective Italian study. Tumori 73: 213–217PubMedGoogle Scholar
  185. Stocker JT, Ishak KG (1978) Undifferentiated (embryonal) sarcoma of the liver. Report of 31 cases. Cancer 42: 336–348PubMedGoogle Scholar
  186. Walker NI, Horn MJ, Storn RW et al. (1992) Undifferentiated (embryonal) sarcoma of the liver. Pathologic findings and long-term survival after complete surgical resection. Cancer 69:52–59Google Scholar
  187. Webber EM, Morrison KB, Pritchard SL et al. (1999) Undifferentiated embryonal sarcoma of the liver: results of clinical management in one center. J Pediatr Surg 34: 1641–1644PubMedGoogle Scholar
  188. Alberti-Flor JJ, O’Hara MF, Weaver F et al. (1985) Malignant fibrous histiocytoma of the liver. Gastroenterology 89: 890–893PubMedGoogle Scholar
  189. Fujita S, Lauwers GY (1998) Primary hepatic malignant fibrous histiocytoma: report of a case and review of the literature. Pathol Int 48: 225–229PubMedGoogle Scholar
  190. Fukuyama M, Koike M (1986) Malignant fibrous histiocytoma arising in the liver. Arch Pathol Lab Med 110: 203–206Google Scholar
  191. Schweyer S, Meyer-Venter R, Lorf T et al. (2000) Malignes fibröses Histiozytom der Leber. Z Gastroenterol 38: 243–248PubMedGoogle Scholar
  192. Anthony PP, Sarsfield P, Clarke T (1990) Primary lymphoma of the liver: clinical ad pathological features of 10 patients. J Clin Pathol 43: 1007–1013PubMedGoogle Scholar
  193. Ata AA, Kamal IA (1965) Primary reticulum cell sarcoma of the liver: a cese report. J Egypt Med Assoc 48: 514–521PubMedGoogle Scholar
  194. Avlonitis VS, Linos D (1999) Primary hepatic lymphoma: a review. Eur J Surg 165: 725–729PubMedGoogle Scholar
  195. Bangerter M, Moog F, Griesshammer M et al. (1997) Usefulness of FDG-PET in diagnosing primary lymphoma of the liver. Int J Hematol 66: 517–520PubMedGoogle Scholar
  196. Baschinsky DY, Weidner N, Baker PB et al. (2001) Primary hepatic anaplastic large-cell lymphoma of T-cell phenotype in acquired immunodeficiency syndrome: a report of an autopsy case and review of the literature. Am J Gastroenterol 96:227–232Google Scholar
  197. Chowla A, Malhi-Chowla N, Chidambaram A et al. (1999) Primary hepatic lymphoma in hepatitis C: case report and review of the literature. Ann Surg 65: 881–883Google Scholar
  198. De Ment SH, Mann RB, Staal SP et al. (1987) Primary lymphomas of the liver. Report of six cases and review of the literature. Am J Clin Pathol 88: 255–263Google Scholar
  199. Gaulard P, Zafrani ES, Mavier P et al. (1986) Peripheral T-cell lymphoma presenting as predominant liver disease: a report of three cases. Hepatology 6: 864–868PubMedGoogle Scholar
  200. Maes M, Depardieu C, Dargent JL et al. (1997) Primary lowgrade B-cell lymphoma of MALT-type occurring in the liver: a study of two cases. J Hepatol 27: 922–927PubMedGoogle Scholar
  201. Nagano K, Fukuda Y, Nakano I et al. (1999) Case report: reactive lymphoid hyperplasia of liver coexisting with chronic thyroiditis: radiographical characteristics of the disorder. J Gastroenterol Hepatol 14: 163–167PubMedGoogle Scholar
  202. Prabhu BM, Medeiros J, Kumar D et al. (1998) Primary hepatic low-grade B-celllymphoma of mucosa-associated lymphoid tissue (MALT) associated with primary biliary cirrhosis. Mod Pathol 11: 404–410PubMedGoogle Scholar
  203. Sato S, Masuda T, Oikawa H et al. (1999) Primary hepatic lymphoma associated with primary biliary cirrhosis. Am J Gastroenterol 94: 1669–1673PubMedGoogle Scholar
  204. Scerpella EG, Villareal AA, Casanova PF et al. (1996) Primary lymphoma of the liver in AIDS: report of a new case and review of the literature. J Clin Gastroenterol 22: 51–53PubMedGoogle Scholar
  205. Wohlfarth A, Wohlfarth M, Rieß R et al. (1999) Das primäre extranodale Non-Hodgkin-Lymphom der Leber. Leber Magen Darm 29: 42–44Google Scholar
  206. Zafrani ES, Gaulard P (1993) Primary lymphoma of the liver. Liver 13: 57–61PubMedGoogle Scholar
  207. Mani H, van Thiel DH (2001) Mesenchymal tumours of the liver. Clin Liver Dis 5: 219–257PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • H. Dancygier

There are no affiliations available

Personalised recommendations